Search

Search Constraints

You searched for: Author/Creator Pierson, Sheila K.

Search Results

3. Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease. Issue 7 (16th May 2018)

4. Predictors of response to anti‐IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data. (11th September 2018)

5. The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry. (4th May 2022)

6. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Issue 10 (28th July 2021)